| Primary |
| Asthma |
51.1% |
| Chronic Obstructive Pulmonary Disease |
18.0% |
| Emphysema |
5.4% |
| Bronchitis |
4.3% |
| Pneumonia |
2.2% |
| Cough |
1.9% |
| Dyspnoea |
1.9% |
| Wheezing |
1.9% |
| Hypertension |
1.7% |
| Nasopharyngitis |
1.5% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Otitis Media |
1.2% |
| Lung Disorder |
1.1% |
| Sinusitis |
1.1% |
| Upper Respiratory Tract Inflammation |
1.1% |
| Bronchopneumonia |
1.0% |
| Hypersensitivity |
0.9% |
| Anxiety |
0.8% |
| Bronchial Hyperreactivity |
0.8% |
| Bronchitis Chronic |
0.8% |
|
| Dyspnoea |
13.7% |
| Wheezing |
10.9% |
| Off Label Use |
9.6% |
| Psychomotor Hyperactivity |
8.5% |
| Asthma |
6.1% |
| Medication Error |
5.4% |
| Tremor |
5.2% |
| Rhinorrhoea |
4.8% |
| Pneumonia |
4.1% |
| Weight Decreased |
3.9% |
| Weight Increased |
3.7% |
| Insomnia |
3.3% |
| Vomiting |
3.3% |
| Rash |
3.0% |
| Drug Ineffective |
2.6% |
| Nasopharyngitis |
2.6% |
| Oropharyngeal Pain |
2.4% |
| Urticaria |
2.4% |
| Wrong Technique In Drug Usage Process |
2.4% |
| Death |
2.2% |
|
| Secondary |
| Asthma |
38.0% |
| Chronic Obstructive Pulmonary Disease |
8.9% |
| Bronchitis |
7.0% |
| Pneumonia |
6.3% |
| Otitis Media |
5.2% |
| Upper Respiratory Tract Inflammation |
4.2% |
| Emphysema |
3.8% |
| Tonsillitis |
3.1% |
| Hypertension |
3.0% |
| Back Pain |
2.3% |
| Cerebral Infarction |
2.3% |
| Cholelithiasis |
2.2% |
| Conjunctivitis |
2.1% |
| Prophylaxis Against Dehydration |
2.1% |
| Pseudocroup |
2.1% |
| Cough |
1.7% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Rhinitis |
1.3% |
| Rhinitis Allergic |
1.3% |
| Wheezing |
1.3% |
|
| Wheezing |
16.2% |
| Weight Increased |
11.4% |
| Off Label Use |
8.6% |
| Pneumonia |
8.6% |
| Dyspnoea |
6.5% |
| Medication Error |
5.9% |
| Tremor |
5.4% |
| Drug Ineffective |
4.3% |
| Rhinorrhoea |
4.3% |
| Tubulointerstitial Nephritis |
3.8% |
| Growth Retardation |
3.2% |
| Acute Tonsillitis |
2.7% |
| Rhinitis |
2.7% |
| Sinusitis |
2.7% |
| Throat Irritation |
2.7% |
| Insomnia |
2.2% |
| Pain In Extremity |
2.2% |
| Rash |
2.2% |
| Urticaria |
2.2% |
| Weight Decreased |
2.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
22.1% |
| Product Used For Unknown Indication |
18.3% |
| Asthma |
18.0% |
| Convulsion |
6.3% |
| Prophylaxis |
6.3% |
| Chronic Obstructive Pulmonary Disease |
4.6% |
| Gastrooesophageal Reflux Disease |
4.1% |
| Pain |
3.3% |
| Hypertension |
2.5% |
| Osteoporosis |
1.8% |
| Anticoagulant Therapy |
1.5% |
| Agitation |
1.3% |
| Bronchospasm |
1.3% |
| Cerebral Palsy |
1.3% |
| Hyperlipidaemia |
1.3% |
| Muscle Spasticity |
1.3% |
| Pyrexia |
1.3% |
| Renal Tubular Acidosis |
1.3% |
| Rhinitis Allergic |
1.3% |
| Acute Coronary Syndrome |
1.0% |
|
| Pneumonia |
13.3% |
| Bronchospasm |
8.9% |
| Myocardial Infarction |
8.9% |
| Pancreatitis Acute |
6.7% |
| Respiratory Distress |
6.7% |
| Skin Lesion |
6.7% |
| Weight Decreased |
6.7% |
| Insomnia |
4.4% |
| Oedema Peripheral |
4.4% |
| Oropharyngeal Pain |
4.4% |
| Suicidal Ideation |
4.4% |
| Urinary Tract Infection |
4.4% |
| Vomiting |
4.4% |
| Abdominal Neoplasm |
2.2% |
| Anosmia |
2.2% |
| Cataract |
2.2% |
| Chest Pain |
2.2% |
| Chills |
2.2% |
| Choking |
2.2% |
| Cough |
2.2% |
|
| Interacting |
|
|
